Dysmenorrhea
Conditions
Interventions
Patients with primary dysmenorrhea treated with LED red light therapy devices:LED Red Light Therapy
Sponsors
The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology
Eligibility
Sex/Gender
All
Age
13 Years to 35 Years
Inclusion criteria
Inclusion criteria: 1.female patients aged 13 to 35 years (inclusive); 2. diagnosis of primary dysmenorrhea; 3.regular menstrual cycles (28 +/- 7 days); 4.self-reported average pain visual analogue scale (VAS) score of >=4 during the most recent two menstrual cycles; 5.voluntary participation with written informed consent provided by the patient and/or legal guardian.
Exclusion criteria
Exclusion criteria: 1.Diagnosis of secondary dysmenorrhea confirmed by gynecological examination and abdominal ultrasonography due to gynecological conditions such as endometriosis, pelvic inflammatory disease, or adenomyosis, or other organic pathologies; 2.Use of oral contraceptives and/or centrally acting medications and/or receipt of physical therapy for dysmenorrhea within the past month; 3. Use of analgesic medications within 24 hours prior to evaluation; 4. Presence of skin ulcers, infections, or other abnormalities at the irradiation site; 5.Severe psychiatric or other disorders impairing the ability to accurately complete VAS pain assessments or objectively describe symptoms; 6.History of phototherapy allergy, malignant tumors, systemic lupus erythematosus, hemorrhagic/hemolytic diseases; 7.Pregnancy, lactation, or planned pregnancy within 3 months after enrollment; 8.Participation in other clinical trials (involving medical devices or pharmaceuticals) within the past month; 9. Other conditions deemed by the investigators to render the participant unsuitable for inclusion, such as anticipated poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| COX Menstrual Pain Symptom Scale;Subject Experience Evaluation;VAS scores during the first, second, and third menstrual periods after subject enrollment;Efficiency rates during the first and second menstrual periods after subject enrollment.; | — |
Countries
China
Contacts
Public ContactGuo Li
The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology
Outcome results
None listed